Impact of the Admission Pathway on the Gender-Related Mortality of Patients With ST-Elevation Myocardial Infarction.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 23 08 2021
revised: 13 11 2021
accepted: 16 11 2021
pubmed: 1 1 2022
medline: 16 4 2022
entrez: 31 12 2021
Statut: ppublish

Résumé

The mortality of women with ST-elevation myocardial infarction (STEMI) exceeds that of men, supposedly the result of older age and co-morbidities. Patients with STEMI can be transported directly to the catherization lab by the emergency medical service (EMS) or to the emergency department (ED) by the EMS, a regular ambulance, or independently. This raises the question whether gender disparity in the transport of patients with STEMI may affect time to therapy and consequently explain the disparate outcome in men and women with STEMI. We analyzed a large nationwide registry of prospectively-recorded patients with acute coronary syndromes in order to determine if there is a survival gap between men and women with STEMI, and to assess the gender-related effect of admission pathway on time intervals and 5-year mortality. Study population included 2,740 patients with STEMI who underwent primary percutaneous coronary interventions, comprising 464 women (17%, median-70 years) and 2,276 men (83%, median-58 years). The unadjusted 5-year mortality of women was higher compared with men (26.4% vs 15.6%, p = 0.001) but adjustment abrogated this survival difference. Regardless of adjustment, the 5-year mortality of patients with STEMI admitted directly to the catherization lab or to the ED by EMS was similar for men and women but significantly lower in the directly admitted patients (p <0.028). In contrast, admission to the ED by non-EMS was associated with markedly worse survival among women. These results indicate that women suspected of STEMI benefit from transportation by the EMS and should use this pathway exclusively to reach the hospital.

Identifiants

pubmed: 34969509
pii: S0002-9149(21)01144-9
doi: 10.1016/j.amjcard.2021.11.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-17

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures The authors have no conflicts of interest to declare.

Auteurs

Simcha R Meisel (SR)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: meisel.simcha@gmail.com.

Ovdat Tal (O)

The Israeli Center for Cardiac Research, Sheba Medical Center, Ramat Gan, Israel.

Ofer Kobo (O)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Majdi Saada (M)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Hamuda Nashed (H)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Rami Abu Fanne (RA)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Ronny Alcalai (R)

The Heart Institute, Hadassah Medical Organization and Faculty of Medicine, Hebrew University, Jerusalem, Israel.

Naama Amsalem (N)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Yaniv Levi (Y)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Jameel Mohsen (J)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Michael Kleiner-Shochat (M)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Ariel Roguin (A)

Heart Institute, Hillel Yaffe Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH